Skip to main content
Retour
Watch Compare

LianBio

Qualité des données : 83%
LIANY
OTC Manufacturing Chemicals
0,12 €
0,00 € (0,00%)
Cap. Boursière: 13,20 M
Prix
0,12 €
Cap. Boursière
13,20 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Negative free cash flow of -83,99 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-41,49%
Au-dessus de la moyenne du secteur (-53,47%)
ROIC-34,05%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio10,06
Interest Coverage-10,71

Valorisation

PE (TTM)
-0,15
Au-dessus de la moyenne du secteur (-1,48)
P/B Ratio0,07
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -0,2 -1,5
P/B 0,1 1,6
ROE % -41,5 -53,5
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

Objectif de Cours des Analystes

Aucune couverture d'analyste disponible

Estimations de Bénéfices

Aucune estimation prévisionnelle disponible

Surprises de Résultats

Derniers 4 trimestres
Trimestre BPA Est. BPA Réel Surprise
Q32023 -0,33 € -0,22 € +33,3%
Q22023 -0,29 € -0,20 € +29,8%
Q12023 -0,27 € -0,22 € +19,3%
Q42022 -0,25 € -0,17 € +32,9%

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -87,98 M
ROE -41,49% ROA -32,48%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -83,99 M
ROIC -34,05% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 10,06
Interest Coverage -10,71 Asset Turnover N/A
Working Capital 232,18 M Tangible Book Value 202,34 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,15 Forward P/E N/A
P/B Ratio 0,07 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -636,09%
Market Cap 13,20 M Enterprise Value -90,25 M
Per Share
EPS (Diluted TTM) -0,82 Revenue / Share N/A
FCF / Share -0,77 OCF / Share -0,77
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 95,46%
SBC-Adj. FCF -102,04 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2022 FY2021
Revenue — —
Net Income -110,29 M -196,30 M
EPS (Diluted) -1,02 -5,71
Gross Profit — —
Operating Income -125,35 M -195,57 M
EBITDA — —
R&D Expenses 59,76 M 158,69 M
SG&A Expenses — —
D&A — —
Interest Expense 4,32 M 243 000,0
Income Tax -333 000,0 518 000,0

Balance Sheet

Annual, most recent first
Metric FY2022 FY2021
Total Assets 319,96 M 426,34 M
Total Liabilities 26,31 M 39,01 M
Shareholders' Equity 259,87 M 353,56 M
Total Debt — —
Cash & Equivalents 79,22 M 228,18 M
Current Assets 312,77 M 399,65 M
Current Liabilities 23,62 M 15,09 M